Conversely, the coexistence of mutations in KRAS and PIK3CA has been described in a significant percentage of colorectal tumors, confirming the parallel activation of ERK/MAPK and PI3K/AKT signaling convergent pathways [15, 32]. This evidence concerns the gene PIK3CG and colorectal neoplasm.